346 related articles for article (PubMed ID: 34477479)
1. The anti-tumor effects of evodiamine on oral squamous cell carcinoma (OSCC) through regulating advanced glycation end products (AGE) / receptor for advanced glycation end products (RAGE) pathway.
Ren L; Lou Y; Sun M
Bioengineered; 2021 Dec; 12(1):5985-5995. PubMed ID: 34477479
[TBL] [Abstract][Full Text] [Related]
2. Cigarette smoke extract induces oral squamous cell carcinoma cell invasion in a receptor for advanced glycation end-products-dependent manner.
Chapman S; Mick M; Hall P; Mejia C; Sue S; Abdul Wase B; Nguyen MA; Whisenant EC; Wilcox SH; Winden D; Reynolds PR; Arroyo JA
Eur J Oral Sci; 2018 Feb; 126(1):33-40. PubMed ID: 29226456
[TBL] [Abstract][Full Text] [Related]
3. Plasma miR-185 is decreased in patients with esophageal squamous cell carcinoma and might suppress tumor migration and invasion by targeting RAGE.
Jing R; Chen W; Wang H; Ju S; Cong H; Sun B; Jin Q; Chu S; Xu L; Cui M
Am J Physiol Gastrointest Liver Physiol; 2015 Nov; 309(9):G719-29. PubMed ID: 26316588
[TBL] [Abstract][Full Text] [Related]
4. Clinical Implications of High-mobility Group Box-1 (HMGB1) and the Receptor for Advanced Glycation End-products (RAGE) in Cutaneous Malignancy: A Systematic Review.
Nguyen AH; Detty SQ; Agrawal DK
Anticancer Res; 2017 Jan; 37(1):1-7. PubMed ID: 28011467
[TBL] [Abstract][Full Text] [Related]
5. The receptor for advanced glycation end-products enhances lung epithelial wound repair: An in vitro study.
Zhai R; Blondonnet R; Ebrahimi E; Belville C; Audard J; Gross C; Choltus H; Henrioux F; Constantin JM; Pereira B; Blanchon L; Sapin V; Jabaudon M
Exp Cell Res; 2020 Jun; 391(2):112030. PubMed ID: 32330509
[TBL] [Abstract][Full Text] [Related]
6. Evodiamine inhibits EPRS expression to regulate glutamate metabolism and proliferation of oral squamous cell carcinoma cells.
Lin LQ; Lv SY; Ren HZ; Li RR; Li L; Pang YQ; Wang J
Kaohsiung J Med Sci; 2024 Apr; 40(4):348-359. PubMed ID: 38243370
[TBL] [Abstract][Full Text] [Related]
7. The expression of receptor for advanced glycation end products is associated with angiogenesis in human oral squamous cell carcinoma.
Sasahira T; Kirita T; Bhawal UK; Ikeda M; Nagasawa A; Yamamoto K; Kuniyasu H
Virchows Arch; 2007 Mar; 450(3):287-95. PubMed ID: 17235565
[TBL] [Abstract][Full Text] [Related]
8. Evodiamine inhibits proliferation and promotes apoptosis of hepatocellular carcinoma cells via the Hippo-Yes-Associated Protein signaling pathway.
Zhao S; Xu K; Jiang R; Li DY; Guo XX; Zhou P; Tang JF; Li LS; Zeng D; Hu L; Ran JH; Li J; Chen DL
Life Sci; 2020 Jun; 251():117424. PubMed ID: 32057900
[TBL] [Abstract][Full Text] [Related]
9. Interaction effect between the receptor for advanced glycation end products (RAGE) and high-mobility group box-1 (HMGB-1) for the migration of a squamous cell carcinoma cell line.
Choi J; Lee MK; Oh KH; Kim YS; Choi HY; Baek SK; Jung KY; Woo JS; Lee SH; Kwon SY
Tumori; 2011; 97(2):196-202. PubMed ID: 21617715
[TBL] [Abstract][Full Text] [Related]
10. Glycation reaction and the role of the receptor for advanced glycation end-products in immunity and social behavior.
Leerach N; Harashima A; Munesue S; Kimura K; Oshima Y; Goto H; Yamamoto H; Higashida H; Yamamoto Y
Glycoconj J; 2021 Jun; 38(3):303-310. PubMed ID: 33108607
[TBL] [Abstract][Full Text] [Related]
11. High-mobility group box 1 induces bone destruction associated with advanced oral squamous cancer via RAGE and TLR4.
Sakamoto Y; Okui T; Yoneda T; Ryumon S; Nakamura T; Kawai H; Kunisada Y; Ibaragi S; Masui M; Ono K; Obata K; Shimo T; Sasaki A
Biochem Biophys Res Commun; 2020 Oct; 531(3):422-430. PubMed ID: 32800556
[TBL] [Abstract][Full Text] [Related]
12. Anti-high-mobility group box-1 (HMGB1) mediates the apoptosis of alveolar epithelial cells (AEC) by receptor of advanced glycation end-products (RAGE)/c-Jun N-terminal kinase (JNK) pathway in the rats of crush injuries.
Zhang BF; Song W; Wang J; Wen PF; Zhang YM
J Orthop Surg Res; 2022 Jan; 17(1):20. PubMed ID: 35033142
[TBL] [Abstract][Full Text] [Related]
13. Low molecular weight heparin suppresses receptor for advanced glycation end products-mediated expression of malignant phenotype in human fibrosarcoma cells.
Takeuchi A; Yamamoto Y; Munesue S; Harashima A; Watanabe T; Yonekura H; Yamamoto H; Tsuchiya H
Cancer Sci; 2013 Jun; 104(6):740-9. PubMed ID: 23421467
[TBL] [Abstract][Full Text] [Related]
14. The advanced glycation end-product N
Menini S; Iacobini C; de Latouliere L; Manni I; Ionta V; Blasetti Fantauzzi C; Pesce C; Cappello P; Novelli F; Piaggio G; Pugliese G
J Pathol; 2018 Jun; 245(2):197-208. PubMed ID: 29533466
[TBL] [Abstract][Full Text] [Related]
15. The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivo.
Riuzzi F; Sorci G; Donato R
J Biol Chem; 2006 Mar; 281(12):8242-53. PubMed ID: 16407300
[TBL] [Abstract][Full Text] [Related]
16. Association of expression of receptor for advanced glycation end products and invasive activity of oral squamous cell carcinoma.
Bhawal UK; Ozaki Y; Nishimura M; Sugiyama M; Sasahira T; Nomura Y; Sato F; Fujimoto K; Sasaki N; Ikeda MA; Tsuji K; Kuniyasu H; Kato Y
Oncology; 2005; 69(3):246-55. PubMed ID: 16127291
[TBL] [Abstract][Full Text] [Related]
17. High mobility group box-1-inducible melanoma inhibitory activity is associated with nodal metastasis and lymphangiogenesis in oral squamous cell carcinoma.
Sasahira T; Kirita T; Oue N; Bhawal UK; Yamamoto K; Fujii K; Ohmori H; Luo Y; Yasui W; Bosserhoff AK; Kuniyasu H
Cancer Sci; 2008 Sep; 99(9):1806-12. PubMed ID: 18616526
[TBL] [Abstract][Full Text] [Related]
18. Advanced glycation end products induce immature angiogenesis in in vivo and ex vivo mouse models.
Chen L; Cui Y; Li B; Weng J; Wang W; Zhang S; Huang X; Guo X; Huang Q
Am J Physiol Heart Circ Physiol; 2020 Mar; 318(3):H519-H533. PubMed ID: 31922896
[TBL] [Abstract][Full Text] [Related]
19. Effects of evodiamine on PI3K/Akt and MAPK/ERK signaling pathways in pancreatic cancer cells.
Hong Z; Wang Z; Zhou B; Wang J; Tong H; Liao Y; Zheng P; Jamshed MB; Zhang Q; Chen H
Int J Oncol; 2020 Mar; 56(3):783-793. PubMed ID: 31922213
[TBL] [Abstract][Full Text] [Related]
20. Dietary advanced glycation end-products, its pulmonary receptor, and high mobility group box 1 in aspiration lung injury.
Smit PJ; Guo WA; Davidson BA; Mullan BA; Helinski JD; Knight PR
J Surg Res; 2014 Sep; 191(1):214-23. PubMed ID: 24814199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
